Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.840
+0.009 (1.11%)
At close: Nov 22, 2024, 4:00 PM
0.805
-0.035 (-4.17%)
After-hours: Nov 22, 2024, 7:56 PM EST
Hoth Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Hoth Therapeutics stock have an average target of 4.75, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts an increase of 465.48% from the current stock price of 0.84.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HOTH stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 4 | 4 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +495.24% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +376.19% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +376.19% | Oct 16, 2024 |
| Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +257.14% | Oct 11, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $5 | Strong Buy | Maintains | $5 | +495.24% | Sep 5, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.34
from -2.30
EPS Next Year
-0.73
from -1.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.24 | -0.61 | -0.68 |
| Avg | -1.34 | -0.73 | -0.66 |
| Low | -1.36 | -0.85 | -0.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.